Basophil degranulation machinery

The basophil degranulation machinery is a complex assembly of receptors, intracellular signaling proteins, and exocytotic components that coordinate the rapid release of inflammatory mediators from basophils. The process is primarily triggered by the cross-linking of the high-affinity IgE receptor (FcεRI) by multivalent allergens, which activates a signaling cascade involving Lyn and Syk tyrosine kinases (Siraganian et al., 2002, PMID: 11812351). This cascade leads to calcium mobilization and the activation of the SNARE (Soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complex, which facilitates the fusion of histamine-containing granules with the plasma membrane (Woska and Gillespie, 2011, PMID: 21242518). This machinery is a critical driver of Type I hypersensitivity reactions and is central to the pathophysiology of allergic asthma, chronic spontaneous urticaria, and anaphylaxis (Stone et al., 2010, PMID: 20159251). Therapeutic interventions often target specific nodes within this machinery, such as Omalizumab, which sequesters IgE to prevent receptor binding, or Fostamatinib, which inhibits Syk kinase to block downstream signaling (MacGlashan et al., 1997, PMID: 9365441; Braselmann et al., 2006, PMID: 16914735). Monitoring basophil activation via biomarkers like CD63 and CD203c is essential for assessing drug efficacy and patient sensitivity in clinical settings (Hoffmann et al., 2015, PMID: 25772471).

Other names

Basophil activation pathwayFcεRI signaling cascadeBasophil exocytosis apparatusFcεRI-mediated degranulation pathway

Inhibition of IgE-FcεRI interaction, inhibition of Spleen tyrosine kinase (Syk) signaling, and stabilization of secretory granule membranes to prevent exocytosis.